Cargando…

Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients

BACKGROUND: Vascular disease is promoted by systemic inflammation that can arise from sites distal to the affected vessels. We sought to characterize the net inflammatory potential of serum from patients with coronary artery disease (CAD) using cultured endothelial cells as a cumulative biosensor. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Cung, Heidi, Aragon, Mario J, Zychowski, Katherine, Anderson, Joe R, Nawarskas, James, Roldan, Carlos, Sood, Akshay, Qualls, Clifford, Campen, Matthew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376347/
https://www.ncbi.nlm.nih.gov/pubmed/25890092
http://dx.doi.org/10.1186/s12967-015-0457-5
_version_ 1782363725409288192
author Cung, Heidi
Aragon, Mario J
Zychowski, Katherine
Anderson, Joe R
Nawarskas, James
Roldan, Carlos
Sood, Akshay
Qualls, Clifford
Campen, Matthew J
author_facet Cung, Heidi
Aragon, Mario J
Zychowski, Katherine
Anderson, Joe R
Nawarskas, James
Roldan, Carlos
Sood, Akshay
Qualls, Clifford
Campen, Matthew J
author_sort Cung, Heidi
collection PubMed
description BACKGROUND: Vascular disease is promoted by systemic inflammation that can arise from sites distal to the affected vessels. We sought to characterize the net inflammatory potential of serum from patients with coronary artery disease (CAD) using cultured endothelial cells as a cumulative biosensor. METHODS AND RESULTS: Serum samples from CAD patients (N = 45) and healthy control subjects (N = 48) were incubated with primary human coronary artery endothelial cells at a 1:10 dilution for 4 h, followed by isolation of the cellular RNA. Alteration of inflammation-responsive elements (adhesion molecules and cytokines) was assessed by gene expression. Specific indicators included intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and interleukin-8 (IL-8). Additionally, the cytokine levels in serum samples from all subjects were quantified. Serum from CAD subjects induced greater endothelial ICAM-1, VCAM-1, and IL-8 expression compared to healthy control serum (p < 0.001 for each analysis). The three indicators of inflammatory potential (ICAM-1, VCAM-1, and IL-8 mRNA) trended independently of each other and also of serum inflammatory biomarkers. IL-8 expression correlated negatively with serum HDL levels but positively correlated with VLDL, plasminogen activator inhibitor-1 and C-reactive protein. Interestingly, serum levels of cytokines in CAD patients were not statistically different from healthy control subjects. A year of follow-up in a sub-group of CAD subjects revealed relatively stable measures. CONCLUSIONS: As yet unidentified circulating factors in the serum of CAD patients appear to activate endothelial cells, leading to upregulation of adhesion molecules and chemokines. This cumulative assay performed well in terms of discriminating patients with CAD compared to healthy subjects, with greater range and specificity than specific inflammatory markers.
format Online
Article
Text
id pubmed-4376347
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43763472015-03-28 Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients Cung, Heidi Aragon, Mario J Zychowski, Katherine Anderson, Joe R Nawarskas, James Roldan, Carlos Sood, Akshay Qualls, Clifford Campen, Matthew J J Transl Med Research BACKGROUND: Vascular disease is promoted by systemic inflammation that can arise from sites distal to the affected vessels. We sought to characterize the net inflammatory potential of serum from patients with coronary artery disease (CAD) using cultured endothelial cells as a cumulative biosensor. METHODS AND RESULTS: Serum samples from CAD patients (N = 45) and healthy control subjects (N = 48) were incubated with primary human coronary artery endothelial cells at a 1:10 dilution for 4 h, followed by isolation of the cellular RNA. Alteration of inflammation-responsive elements (adhesion molecules and cytokines) was assessed by gene expression. Specific indicators included intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and interleukin-8 (IL-8). Additionally, the cytokine levels in serum samples from all subjects were quantified. Serum from CAD subjects induced greater endothelial ICAM-1, VCAM-1, and IL-8 expression compared to healthy control serum (p < 0.001 for each analysis). The three indicators of inflammatory potential (ICAM-1, VCAM-1, and IL-8 mRNA) trended independently of each other and also of serum inflammatory biomarkers. IL-8 expression correlated negatively with serum HDL levels but positively correlated with VLDL, plasminogen activator inhibitor-1 and C-reactive protein. Interestingly, serum levels of cytokines in CAD patients were not statistically different from healthy control subjects. A year of follow-up in a sub-group of CAD subjects revealed relatively stable measures. CONCLUSIONS: As yet unidentified circulating factors in the serum of CAD patients appear to activate endothelial cells, leading to upregulation of adhesion molecules and chemokines. This cumulative assay performed well in terms of discriminating patients with CAD compared to healthy subjects, with greater range and specificity than specific inflammatory markers. BioMed Central 2015-03-22 /pmc/articles/PMC4376347/ /pubmed/25890092 http://dx.doi.org/10.1186/s12967-015-0457-5 Text en © Cung et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Cung, Heidi
Aragon, Mario J
Zychowski, Katherine
Anderson, Joe R
Nawarskas, James
Roldan, Carlos
Sood, Akshay
Qualls, Clifford
Campen, Matthew J
Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients
title Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients
title_full Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients
title_fullStr Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients
title_full_unstemmed Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients
title_short Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients
title_sort characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376347/
https://www.ncbi.nlm.nih.gov/pubmed/25890092
http://dx.doi.org/10.1186/s12967-015-0457-5
work_keys_str_mv AT cungheidi characterizationofanovelendothelialbiosensorassayrevealsincreasedcumulativeseruminflammatorypotentialinstabilizedcoronaryarterydiseasepatients
AT aragonmarioj characterizationofanovelendothelialbiosensorassayrevealsincreasedcumulativeseruminflammatorypotentialinstabilizedcoronaryarterydiseasepatients
AT zychowskikatherine characterizationofanovelendothelialbiosensorassayrevealsincreasedcumulativeseruminflammatorypotentialinstabilizedcoronaryarterydiseasepatients
AT andersonjoer characterizationofanovelendothelialbiosensorassayrevealsincreasedcumulativeseruminflammatorypotentialinstabilizedcoronaryarterydiseasepatients
AT nawarskasjames characterizationofanovelendothelialbiosensorassayrevealsincreasedcumulativeseruminflammatorypotentialinstabilizedcoronaryarterydiseasepatients
AT roldancarlos characterizationofanovelendothelialbiosensorassayrevealsincreasedcumulativeseruminflammatorypotentialinstabilizedcoronaryarterydiseasepatients
AT soodakshay characterizationofanovelendothelialbiosensorassayrevealsincreasedcumulativeseruminflammatorypotentialinstabilizedcoronaryarterydiseasepatients
AT quallsclifford characterizationofanovelendothelialbiosensorassayrevealsincreasedcumulativeseruminflammatorypotentialinstabilizedcoronaryarterydiseasepatients
AT campenmatthewj characterizationofanovelendothelialbiosensorassayrevealsincreasedcumulativeseruminflammatorypotentialinstabilizedcoronaryarterydiseasepatients